Summary & Key Points
"On Thursday, December 15, 2022, Phase 2 of the training for data collection agents for the evaluation of the cervical cancer screening program rollout in Côte d'Ivoire, the CASCADE Study, took place."
On Thursday, December 15, 2022, Phase 2 of the training for data collection agents took place to evaluate the rollout of cervical cancer screening programs in Côte d’Ivoire, the CASCADE study.
This phase of routine cervical cancer screening data collection for the 2010–2021 period in CASCADE began in April 2022 at sites in Abidjan under the supervision of the National Cancer Control Program (PNLCa). Nearly 13,000 screening visits have been digitized using the REDCap® application across 13 sites in Abidjan.
This training aimed to equip newly recruited data collection agents in Bouaké and Daloa and provide refresher training for those in Abidjan. It brought together resource persons from the National Cancer Control Program (3), the PAC-CI Program (3), and 9 data collection agents.
Ultimately, data from 47 screening sites will be digitized and will help better understand the impact of major socio-health events and public health strategies on the performance of the secondary prevention program for cervical cancer, as well as estimate the screening coverage rate for the 2010–2024 period in Abidjan, Bouaké, and Daloa, the three regions most affected by this program in Côte d’Ivoire.
